Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, December 22, 2021
[ Wed, Dec 22nd 2021
] - WOPRAI
[ Wed, Dec 22nd 2021
] - WOPRAI
Tue, December 21, 2021
[ Tue, Dec 21st 2021
] - WOPRAI
[ Tue, Dec 21st 2021
] - WOPRAI
[ Tue, Dec 21st 2021
] - WOPRAI
[ Tue, Dec 21st 2021
] - WOPRAI
[ Tue, Dec 21st 2021
] - WOPRAI
[ Tue, Dec 21st 2021
] - WOPRAI
[ Tue, Dec 21st 2021
] - WOPRAI
[ Tue, Dec 21st 2021
] - WOPRAI
[ Tue, Dec 21st 2021
] - WOPRAI
[ Tue, Dec 21st 2021
] - WOPRAI
[ Tue, Dec 21st 2021
] - WOPRAI
[ Tue, Dec 21st 2021
] - WOPRAI
[ Tue, Dec 21st 2021
] - WOPRAI
[ Tue, Dec 21st 2021
] - WOPRAI
[ Tue, Dec 21st 2021
] - WOPRAI
[ Tue, Dec 21st 2021
] - WOPRAI
[ Tue, Dec 21st 2021
] - WOPRAI
[ Tue, Dec 21st 2021
] - WOPRAI
[ Tue, Dec 21st 2021
] - WOPRAI
[ Tue, Dec 21st 2021
] - WOPRAI
[ Tue, Dec 21st 2021
] - WOPRAI
[ Tue, Dec 21st 2021
] - WOPRAI
[ Tue, Dec 21st 2021
] - WOPRAI
[ Tue, Dec 21st 2021
] - WOPRAI
[ Tue, Dec 21st 2021
] - WOPRAI
Brian Skorney Maintained (BIIB) at Hold with Decreased Target to $258 on, Dec 21st, 2021
Brian Skorney of Baird, Maintained "Biogen Inc." (BIIB) at Hold with Decreased Target from $296 to $258 on, Dec 21st, 2021.
Brian has made no other calls on BIIB in the last 4 months.
There are 15 other peers that have a rating on BIIB. Out of the 15 peers that are also analyzing BIIB, 6 agree with Brian's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Mohit Bansal of "Wells Fargo" Initiated at Hold and Held Target at $250 on, Thursday, December 9th, 2021
- Salveen Richter of "Goldman Sachs" Initiated at Hold and Held Target at $271 on, Monday, December 6th, 2021
- Brian Abrahams of "RBC Capital" Maintained at Hold with Decreased Target to $277 on, Friday, November 19th, 2021
- Salim Syed of "Mizuho" Maintained at Hold with Decreased Target to $270 on, Tuesday, October 26th, 2021
- Alethia Young of "Cantor Fitzgerald" Maintained at Hold with Decreased Target to $327 on, Friday, October 15th, 2021
- Carter Gould of "Barclays" Maintained at Hold with Decreased Target to $290 on, Friday, October 8th, 2021
These are the ratings of the 9 analyists that currently disagree with Brian
- Marc Goodman of "SVB Leerink" Maintained at Buy with Decreased Target to $325 on, Monday, December 20th, 2021
- Evan Seigerman of "BMO Capital" Initiated at Buy and Held Target at $315 on, Friday, November 19th, 2021
- Phil Nadeau of "Cowen & Co." Maintained at Buy with Decreased Target to $375 on, Thursday, October 21st, 2021
- Ami Fadia of "Needham" Maintained at Strong Buy with Decreased Target to $386 on, Thursday, October 21st, 2021
- Jay Olson of "Oppenheimer" Maintained at Buy with Decreased Target to $390 on, Thursday, October 21st, 2021
- Matthew Harrison of "Morgan Stanley" Maintained at Buy with Decreased Target to $440 on, Thursday, October 21st, 2021
- Paul Matteis of "Stifel" Maintained at Strong Buy with Decreased Target to $344 on, Friday, October 15th, 2021
- Michael Yee of "Jefferies" Maintained at Strong Buy with Decreased Target to $400 on, Friday, October 8th, 2021
- Colin Bristow of "UBS" Maintained at Strong Buy with Decreased Target to $442 on, Thursday, September 16th, 2021
